Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Chlorothiazide sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlorothiazide sodium and what is the scope of chlorothiazide sodium freedom to operate?

Chlorothiazide sodium
is the generic ingredient in two branded drugs marketed by Oak Pharms Akorn, Sun Pharma Global, Luitpold, Sagent Pharms, Mylan Institutional, and Fresenius Kabi Usa, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-one drug master file entries for chlorothiazide sodium. Seven suppliers are listed for this compound.

Summary for Generic Name: chlorothiazide sodium

Drug Master File Entries: see list41
Suppliers / Packagers: see list7
Bulk Api Vendors: see list56
Clinical Trials: see list935
Patent Applications: see list1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chlorothiazide sodium at DailyMed

Pharmacology for Ingredient: chlorothiazide sodium

Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
chlorothiazide sodium
INJECTABLE;INJECTION090896-001Oct 16, 2009APRXNoNo► Subscribe► Subscribe
Sun Pharma Global
chlorothiazide sodium
INJECTABLE;INJECTION091546-001Jul 26, 2011APRXNoNo► Subscribe► Subscribe
Sagent Pharms
chlorothiazide sodium
INJECTABLE;INJECTION202462-001May 29, 2015APRXNoNo► Subscribe► Subscribe
chlorothiazide sodium
INJECTABLE;INJECTION202561-001Apr 22, 2013APRXNoNo► Subscribe► Subscribe
Mylan Institutional
chlorothiazide sodium
INJECTABLE;INJECTION202493-001Jun 18, 2014APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus